S&P 500   2,998.41 (+1.09%)
DOW   27,036.26 (+0.93%)
QQQ   193.44 (+1.22%)
AAPL   235.72 (-0.06%)
MSFT   141.45 (+1.36%)
AMZN   1,759.37 (+1.32%)
NVDA   199.18 (+6.78%)
MU   46.42 (+3.48%)
GE   8.87 (+1.72%)
AMD   30.73 (+0.66%)
T   37.89 (+1.12%)
PRI   123.75 (+1.88%)
NFLX   284.71 (-0.29%)
BAC   29.90 (+2.61%)
DIS   130.07 (+0.29%)
S&P 500   2,998.41 (+1.09%)
DOW   27,036.26 (+0.93%)
QQQ   193.44 (+1.22%)
AAPL   235.72 (-0.06%)
MSFT   141.45 (+1.36%)
AMZN   1,759.37 (+1.32%)
NVDA   199.18 (+6.78%)
MU   46.42 (+3.48%)
GE   8.87 (+1.72%)
AMD   30.73 (+0.66%)
T   37.89 (+1.12%)
PRI   123.75 (+1.88%)
NFLX   284.71 (-0.29%)
BAC   29.90 (+2.61%)
DIS   130.07 (+0.29%)
Log in

Galena Biopharma Stock Price, News & Analysis (NYSE:SLS)

$0.13
0.00 (0.00 %)
(As of 10/15/2019 12:23 PM ET)
Today's Range
$0.13
Now: $0.13
$0.13
50-Day Range
$0.11
MA: $0.13
$0.15
52-Week Range
$0.10
Now: $0.13
$2.46
Volume3.48 million shs
Average Volume10.80 million shs
Market Capitalization$29.39 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Develop biopharmaceuticals

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorHealth Technology
CUSIPN/A
WebN/A
Phone(917) 438-4353

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$29.39 million
Next Earnings Date11/21/2019 (Estimated)
OptionableNot Optionable

Receive SLS News and Ratings via Email

Sign-up to receive the latest news and ratings for SLS and its competitors with MarketBeat's FREE daily newsletter.


Galena Biopharma (NYSE:SLS) Frequently Asked Questions

What is Galena Biopharma's stock symbol?

Galena Biopharma trades on the New York Stock Exchange (NYSE) under the ticker symbol "SLS."

How were Galena Biopharma's earnings last quarter?

Galena Biopharma, Inc. (NYSE:SLS) released its quarterly earnings data on Wednesday, August, 14th. The company reported ($0.13) earnings per share (EPS) for the quarter. View Galena Biopharma's Earnings History.

When is Galena Biopharma's next earnings date?

Galena Biopharma is scheduled to release their next quarterly earnings announcement on Thursday, November 21st 2019. View Earnings Estimates for Galena Biopharma.

Has Galena Biopharma been receiving favorable news coverage?

News coverage about SLS stock has trended somewhat positive recently, InfoTrie Sentiment reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Galena Biopharma earned a news sentiment score of 1.4 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Galena Biopharma.

Who are some of Galena Biopharma's key competitors?

What other stocks do shareholders of Galena Biopharma own?

Who are Galena Biopharma's key executives?

Galena Biopharma's management team includes the folowing people:
  • Angelos M. Stergiou, President, Chief Executive Officer & Director
  • Aleksey N. Krylov, Chief Financial Officer, Treasurer & Director
  • Nicholas J. Sarlis, Director, Chief Medical Officer & Senior VP
  • Barbara A. Wood, Secretary, Executive VP & General Counsel
  • Gregory M. Torre, Director, Chief Regulatory Officer & Senior VP

How do I buy shares of Galena Biopharma?

Shares of SLS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Galena Biopharma's stock price today?

One share of SLS stock can currently be purchased for approximately $0.12.

How big of a company is Galena Biopharma?

Galena Biopharma has a market capitalization of $27.34 million. View Additional Information About Galena Biopharma.

How can I contact Galena Biopharma?

The company can be reached via phone at (917) 438-4353.


MarketBeat Community Rating for Galena Biopharma (NYSE SLS)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  96 (Vote Outperform)
Underperform Votes:  109 (Vote Underperform)
Total Votes:  205
MarketBeat's community ratings are surveys of what our community members think about Galena Biopharma and other stocks. Vote "Outperform" if you believe SLS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SLS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Featured Article: Equity Income

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel